Patients will attend follow-up visits for a minimum of 12 months to a maximum of 36 months (or common study end date, whichever occurs first). The purpose of this observational registry is to collect additional information on the safety and effectiveness of the SYNERGY stent in patients with STEMI. If patients receive a SYNERGY everolimus-eluting stent during their PCI procedure, they will also be enrolled in the SYNERGY stent registry. - Scratch resistant 8-base curve lenses - Polycarbonate lenses provide 99 protection against harmful UV. Usually ‘drug-eluting’ stents are used that have a polymer coating containing a drug, which is released slowly to reduce the risk of the heart artery renarrowing. SynergyKM Mouse Broadcaster Article Links. PCI involves inserting a small tube into an artery in the wrist or groin under local anaesthetic, passing a balloon into the blocked heart artery to open it and implantation of a metal stent into the wall of the artery to keep it open. This study will include patients who have undergone a procedure known as Percutaneous Coronary Intervention (PCI) to treat a type of heart attack called an ST Elevation Myocardial Infarction (STEMI). In addition to usual medicines prescribed for this condition, participants in this trial may receive one, both, or neither medication by random assignment. CLEAR SYNERGY (OASIS) is an international clinical trial evaluating two medications, colchicine and spironolactone, to determine if they can reduce damage to the heart and prevent future cardiovascular events after a heart attack (such as a further heart attack or heart failure).
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |